stay up to date on this topic
global shortages in testing supplies for sexually transmitted infections (stis) and other laboratory equipment are impacting access, according to health canada.
during the pandemic, laboratories have been
facing a global shortagein critical equipment, including reagents, test tubes and gloves. the shortage does not only affect covid tests and has impacted the test patients can receive for stis.
“covid-19 public health measures have restricted the delivery of, and access to, sexually transmitted and blood-borne infections (stbbi) prevention, testing and treatment services, including harm reduction services across canada,” said a spokesperson for health canada.
“driven by the impact of the determinants of health, including stigma and discrimination, it is anticipated that these restrictions have had greater impacts on some key populations.”
in response to these concerns, the public health agency of canada surveyed organizations that provide stbbi services to understand the impact the covid response is having on the sexual health of canadians. data from this study is still to come.
global concerns over access to sti tests and harm prevention
in september, the us centres for disease control and prevention
issued a letteraddressing the shortage of sti test kits and laboratory supplies and advising laboratories to prioritize tests for at-risk populations. the biggest impact was on chlamydia and gonorrhea nucleic acid amplification tests
since then, the american society for microbiology (asm)
began collecting informationregarding laboratory shortages during the pandemic. throughout the fall, outside of shortages in reagents for covid testing, laboratories primarily reported a shortage in testing supplies for stis, followed by bacteria.